ArticleCureus2025
Role of Ultrasound-Guided Marker Placement in Breast Lesion for Precise Localization, Surgical Resection, Neoadjuvant Chemotherapy Response, and Post-Chemotherapy Follow-Up.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hydrogel-Coated Clips Are Associated with a Higher Risk of Dislocation After Ultrasound-Guided Breast Biopsy.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective To evaluate the effectiveness of ultrasound-guided marker placement in the precise localization of breast lesions, facilitate accurate surgical resection, and monitor tumor response during and after neoadjuvant chemotherapy. Materials and methods From January 2022 to December 2022, 70 female patients with breast carcinoma underwent a trial of metallic marker insertion into the tumor. The markers were made by cutting 5CC disposable syringe needles having a total length of 5 mm. These markers were inserted using a 16 G LP needle having a length of 10 cm. Results Among 70 female breast cancer patients (mean age 47.9 ± 8.0 years), ultrasound-guided metallic markers enabled precise tumor localization before, during, and after neoadjuvant chemotherapy. In 45 patients receiving chemotherapy, tumor size significantly decreased from 3.66 ± 0.69 cm to 0.61 ± 0.21 cm (p < 0.00001). Marker-guided surgery achieved complete tumor excision with negative margins. Intraoperative imaging and postoperative histopathology confirmed accurate localization and successful resection. Conclusion Ultrasound-guided marker placement enables precise tumor localization after neoadjuvant chemotherapy, improving surgical accuracy and breast cancer treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.